Findings
In this quality improvement study with a post hoc bayesian analysis of the Pragmatic Randomized Optimal Platelet and Plasma Ratios Trial, there was a 93% and 87% probability that balanced transfusion strategies were superior to red blood cell–heavy approaches with regards to 24-hour and 30-day mortality, respectively.